Cardio Diagnostics Holdings, Inc.(CDIO)Earnings, Financials & Key RatiosCardio Diagnostics Holdings, Inc. (CDIO) stock price & volume — 10-year historical chart
Investment Thesis • Updated 2026Q1
the company's inability to generate meaningful revenue, coupled with a persistent quarterly cash burn of $1.6 million, suggests a high risk of continued shareholder dilution and capital exhaustion.
Cardio Diagnostics Holdings, Inc. (CDIO) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Cardio Diagnostics Holdings, Inc. (CDIO) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 15, 2026 | $0.63 | $2,680 |
| Q2 2026 | Mar 13, 2026 | $0.80vs $1.80+55.6% | $3,555vs $250,000-98.6% |
| Q4 2025 | Nov 12, 2025 | $0.98vs $1.80+45.6% | $2,855vs $150,000-98.1% |
| Q3 2025 | Aug 14, 2025 | $0.97vs $1.80+46.1% | $7,475vs $75,000-90.0% |
Recent stock market news and headlines for Cardio Diagnostics Holdings, Inc. (CDIO)
CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics today announced that Atlas Healthcare Physicians (AHP) will cover Cardio Diagnostics' tests, Epi+Gen CHD™ and PrecisionCHD™.
Key metrics vs top competitors for Cardio Diagnostics Holdings, Inc. (CDIO)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $2.08 | $4.31M | -0.56 | -57.51% | -43832.49% | -78.62% | — | |
| $89.40 | $2.95B | 61.66 | 4.11% | 6.98% | 6.59% | — | |
| $104.91 | $20.02B | -95.37 | 17.69% | -6.4% | -8.66% | — | |
| $272.31 | $39B | -179.15 | 35.9% | -9.05% | -15.13% | — | |
| $67.29 | $2.33B | 13.82 | 37.13% | 27.04% | 41.92% | — | |
| $76.01 | $16.97B | 30.53 | 1.74% | 13.18% | 11.01% | — |
Cardio Diagnostics Holdings, Inc. (CDIO) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Cardio Diagnostics Holdings, Inc. (CDIO) SEC filings — annual & quarterly reports (10-K, 10-Q)
Feb 19, 2026·SEC
Oct 15, 2025·SEC
May 28, 2025·SEC
Get notified when CDIO posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Cardio Diagnostics Holdings, Inc. (CDIO) stock FAQ — growth, dividends, profitability & financials explained
Cardio Diagnostics Holdings, Inc. (CDIO) reported $0.0M in revenue for fiscal year 2025.
Cardio Diagnostics Holdings, Inc. (CDIO) saw revenue decline by 57.5% over the past year.
Cardio Diagnostics Holdings, Inc. (CDIO) reported a net loss of $6.7M for fiscal year 2025.
Cardio Diagnostics Holdings, Inc. (CDIO) has a return on equity (ROE) of -78.6%. Negative ROE indicates the company is unprofitable.
Cardio Diagnostics Holdings, Inc. (CDIO) had negative free cash flow of $6.1M in fiscal year 2025, likely due to heavy capital investments.
